A two-day dry run for corona virus vaccine program started this morning in Andhra Pradesh, Punjab, Gujarat, and Assam. Focus on management of possible adverse events after immunisation, and dry runs that include checks on cold storage; and transportation arrangements will be part of the program that will be carried out in the chosen districts in each state.
All the states will report the observations recorded; during the program to the Centre. The government plans to cover 30 crore people in the first phase when it rolls out a vaccine for the corona virus.
A total of 2,360 training sessions have been; held so far, and 7,000 officials have been trained, including medical officers and vaccinators. In Andhra Pradesh, the dry run that will take place in Krishna districts is aimed at testing the planned operations and the laid-out mechanisms in the state, Health Commissioner Katamaneni Bhaskar told reporters on Sunday.
By news agency PTI, he was quoted as saying “It will provide insights into any gaps or bottlenecks so that those could be addressed; before the commencement of the actual drive.”
Across the four states, five sessions will be held at identified locations; with 25 test pre-identified beneficiaries healthcare workers for each session. Feasibility of Co-WIN, an electronic application that identifies beneficiaries and prerequisites; for vaccine introduction as per operational guidelines will be assessed.
AEFI (Adverse Event Following Immunisation) panels will be informed and treatment centres will also be identified if the vaccine triggers an adverse response in any of the beneficiaries. Mr. Bhaskar said, “After the dry run, we will prepare a report for the State Task Force, which will review the feedback; and guide us on further actions.” The report will also be submitted to the Union Health Ministry, the Commissioner said.
In Assam, the health department will roll out the dry run in two districts – Sonitpur and Nalbari districts. The end-to-end testing; of the COVID-19 vaccination process includes vaccine and logistics mobilization to the sites in the two districts, as per officials.
Earlier this month, Bharat Biotech, Serum Institute of India, and Pfizer had; applied to the Drugs Controller General of India (DCGI), seeking emergency use; authorisation for their COVID-19 vaccines.